These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15262487)

  • 1. Anti-beta 2-glycoprotein I antibodies do not increase TF activity by de-encryption.
    Wolberg AS; Roubey RA
    Thromb Res; 2004; 114(1):67-71. PubMed ID: 15262487
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-beta 2-glycoprotein I antibodies and anti-endothelial cell antibodies induce tissue factor in endothelial cells.
    Kornberg A; Renaudineau Y; Blank M; Youinou P; Shoenfeld Y
    Isr Med Assoc J; 2000 Jul; 2 Suppl():27-31. PubMed ID: 10909414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma thrombomodulin in different subgroups of patients with antiphospholipid and anti beta(2) glycoprotein I antibodies.
    Martinuzzo ME; Forastiero RR; Carreras LO
    Thromb Haemost; 1996 Jun; 75(6):972-3. PubMed ID: 8822596
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of autoantibody-induced monocyte tissue factor expression.
    Wolberg AS; Roubey RA
    Thromb Res; 2004; 114(5-6):391-6. PubMed ID: 15507269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-avidity anti-beta glycoprotein I antibodies highly correlate with thrombosis in contrast to low-avidity anti-beta glycoprotein I antibodies.
    de Laat B; Derksen RH; de Groot PG
    J Thromb Haemost; 2006 Jul; 4(7):1619-21. PubMed ID: 16839363
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
    Galli M
    Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of chemokine-induced platelet activation in thrombophilic diathesis of antiphospholipid syndrome.
    Kubota T; Fukuya Y; Hashimoto R; Kanda T; Suzuki H; Okamura Y; Nanki T; Miyasaka N; Umezawa K
    Ann N Y Acad Sci; 2009 Sep; 1173():137-45. PubMed ID: 19758142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
    Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of the antiphospholipid syndrome.
    de Groot PG; Derksen RH
    J Thromb Haemost; 2005 Aug; 3(8):1854-60. PubMed ID: 16102052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome.
    Cucnik S; Bozic B; Kveder T; Tomsic M; Rozman B
    Ann N Y Acad Sci; 2005 Jun; 1051():141-7. PubMed ID: 16126953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry?
    Asherson RA; Shoenfeld Y
    J Rheumatol; 2000 Jan; 27(1):12-4. PubMed ID: 10648011
    [No Abstract]   [Full Text] [Related]  

  • 16. The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies.
    Bohgaki M; Atsumi T; Yamashita Y; Yasuda S; Sakai Y; Furusaki A; Bohgaki T; Amengual O; Amasaki Y; Koike T
    Int Immunol; 2004 Nov; 16(11):1633-41. PubMed ID: 15466912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway and the antiphospholipid syndrome.
    Roubey RA
    J Autoimmun; 2000 Sep; 15(2):217-20. PubMed ID: 10968913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antigenic structures recognized by anti-beta 2-glycoprotein I autoantibodies].
    Kasahara H
    Hokkaido Igaku Zasshi; 2003 Nov; 78(6):515-9, 521-3, 525-7. PubMed ID: 14672039
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiphospholipid antibody testing: which are most useful for diagnosis?
    Bertolaccini ML; Hughes GR
    Rheum Dis Clin North Am; 2006 Aug; 32(3):455-63. PubMed ID: 16880078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.